Send feedback

ALDOA p.Arg313Cys

c.937C>T · rs779421883 · VCV1416209

Uncertain significance Multiple submitters
Classification
Uncertain significance
ClinVar
Review
Multiple submitters ★★☆☆
ClinVar · 3 submitters
AlphaMissense
likely pathogenic
0.8383 · ACMG-weighted
gnomAD v4.1
Rare
very rare (popmax 0.00223%, eas)
Missense predictors
3/3 damaging
AlphaMissense, REVEL, SaProt
Conditions
1
glycogen storage disease due to aldolase A deficiency

Computational evidence

Protein change
AlphaMissense0.8383likely pathogenic
REVEL0.887moderately pathogenic-leaning
SaProtLLR -14.78damaging
⇒ AlphaMissense, REVEL and SaProt all call this damaging.
Splicing
SpliceAI—not assessed · no allele here is in the release
Constraint at this position
ConservationphyloP 4.9GERP 1.9, phastCons 1
Regional constrainto/e 0.91unconstrained · MANE · 3,311 bp · p 0.028 · regional, not allelic
Overall
CADD32.0PHRED · no single calibrated threshold — expert panels disagree

ClinVar classifies this uncertain; the computational predictors unanimously lean damaging — a triage signal, not a reclassification

AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.

⚠ Isoform check: AlphaMissense numbered on a different transcript (AM R259C vs ClinVar R313C) — verify the residue.

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 0.00223% East Asian · 1/44,892 alleles
Filtering AF 0.00145% ClinGen BA1/BS1 input FAF95, joint · FAF99 0.00123%
Overall 0.0018% 29/1,613,592 alleles · very rare
Ancestry group Frequency 1 in
Ashkenazi Jewishnot grpmax-eligible 0.00338% 29,606
East Asiangrpmax 0.00223% 44,892
European (non-Finnish) 0.00212% 47,201
Remaining individualsnot grpmax-eligible 0.0016% 62,476
South Asian 0.0011% 91,082

Ashkenazi Jewish shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
ALDOA
Protein
p.Arg313Cys
Coding
c.937C>T
MANE Select
NM_001243177
dbSNP
rs779421883
Type
single nucleotide variant
Location
chr16:30069649 (GRCh38)
Gene constraint
LOEUF 0.821 · pLI <0.01 · ClinGen HI gene assoc. with recessive phenotype (gnomAD)
Structure
AlphaFold pLDDT 96.53 · 8 PDB
Residue 313
a UniProt-annotated variant site (in gsd12); an α-helix
Full ALDOA gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Disease context

glycogen storage disease due to aldolase A deficiency — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatments

For Glycogen storage disease due to aldolase A deficiency (Orphanet):

Inheritance
Autosomal recessive
Onset
Neonatal

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/aldoa-p-arg313cys (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown